Hollow Fiber Filtration Market worth $597 million by 2026 - Exclusive Report by MarketsandMarkets™12/9/2021 According to the new market research report "Hollow Fiber Filtration Market by Material (Polymer (PES, PVDF), Ceramic), Technique (Microfiltration, Ultrafiltration), Application (Harvest & Clarification, Concentration, Diafiltration), End Users (Pharma, Biotech, CRO, CMO) - Global Forecast to 2026", published by MarketsandMarkets™, is projected to reach USD 597 million by 2026 from USD 303 million in 2021, at a CAGR of 14.5% during the forecast period.
Browse and in-depth TOC on "Hollow Fiber Filtration Market" 194 - Tables 35 - Figures 184 – Pages Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267011039 The growth of the global Hollow Fiber Filtration Market is driven by factors such as the rising preference for continuous manufacturing, increasing use of single use technologies, and the rising biopharmaceutical industry. In addition, emerging economies, and increased investment cell-based research are expected to provide significant growth opportunities for players in the market. The PS/PES material segment accounted for the largest share of the Hollow Fiber Filtration Market in 2020. Based on material, the market is segmented into polymeric and ceramic. The polymeric segment is further sub segmented into PS/PES, Polyvinylidene fluoride (PVDF), and Other polymeric materials. In 2020, PS/PES membrane filters accounted for the largest market share as they are designed to eliminate particulates during standard filtration. They have low protein and drug binding characteristics and are stable at alkaline pH. PS/PES membranes are recommended for aqueous applications and for biological samples. These membranes offer high product recoveries due to characteristics such as low affinity and adsorption. In biopharmaceutical industries, PS/PES membranes are mostly used for ultrafiltration in downstream processing, product concentration, and the filtration of biological and pharmaceutical solutions. The continuous cell perfusion segment accounted for the largest market share of the Hollow Fiber Filtration Market in 2020. Based on application type, the market is segmented into continuous cell perfusion, harvest and clarification, and concentration and diafiltration. In 2020, continuous cell perfusion accounted for the largest market share due to the advantages of hollow fibers in continuous cell perfusion, such as enabling efficient cell separation (with low shear) and allowing robust large-scale manufacturing. Request Sample Pages:-https://www.marketsandmarkets.com/requestsampleNew.asp?id=267011039 The Asia Pacific region is the fastest-growing region of the Hollow Fiber Filtration Market in 2020. The Asia Pacific market is projected to witness the highest growth rate during the forecast period, primarily due to innovation, a giant talent pool of scientists, low labor, and manufacturing costs. The region has also witnessed mass production because of technology and a rise in continuous manufacturing instead of batch production in the previous era. Asia Pacific region is also a lucrative market for foreign investors, with key market players having their presence in the region. Over the last decade, CMOs in the Asia Pacific region have impacted the global pharmaceutical manufacturing market. Several small and medium-scale CMOs set up in APAC have obtained US FDA approval for their operations and completed GMP certifications, thus driving the regions market. Prominent players in the Hollow Fiber Filtration Market are Repligen Corporation (US), Danaher (US), Asahi Kasei Corporation (Japan), Parker-Hannifin Corp (US), Sartorius Stedim Biotech S.A (France), TOYOBO CO., LTD (Japan), and Cantel Medical (US). The key players in this market are focusing on strategic expansions, and acquisition to expand their presence in the market. Browse Related Reports: Pharmaceutical Membrane Filtration Market by Product (Filter, System), Technique (Microfiltration, Nanofiltration), Material (PES, PVDF, PTFE), Application (Final Product (Sterile Filtration), Raw Material, Cell Separation, Water) - Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-membrane-filtration-market-255408031.html Pharmaceutical Filtration Market by Product (Membrane Filters, Single-Use Systems), Technique (Microfiltration, Ultrafiltration), Application (Final Product Processing, Raw material), Scale of Operation (Manufacturing, Pilot, R&D) - Global Forecast to 2021 https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-filtration-market-209343847.html
0 Comments
Cell Analysis Market Worth $22.7 Billion by 2024 - Exclusive Market Report by MarketsandMarkets™12/8/2021 According to the new market research report "Cell Analysis Market by Product [Microscope, Spectrophotometers, Flow cytometry (Software, Accessories)], Process (Cell Viability, Cell Proliferation, Signal Transduction), End User (Pharma, Research, Biotechnology Companies) - Global Forecast to 2024", published by MarketsandMarkets™, the Cell Analysis Market is expected to reach USD 22.7 billion by 2024 from USD 16.0 billion in 2019, at a CAGR of 7.2%. from 2019 to 2024
Browse and in-depth TOC on "Cell Analysis Market" 209 - Tables 36 - Figures 230 - Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157543946 The Increasing government funding for cell-based research and the rising incidence of chronic and infectious diseases are the major factors driving the growth of this market. In 2018, the flow cytometry products segment accounted for the largest share of the cell analysis market Based on product, the Cell Analysis Market is broadly categorized into microscopes, flow cytometry products, spectrophotometers, qPCR products, cell counters, cell microarrays, high-content screening (HCS) systems, and other products. The flow cytometry products segment accounted for the largest market share in 2018. The large share of this segment is primarily attributed to technological advancements, the increasing adoption of flow cytometry techniques in research and academia, growing public-private initiatives in the field of immunology and immuno-oncology research, and the rising incidence and prevalence of chronic diseases. The pharmaceutical & biotechnology companies and CROs segment to grow at the highest CAGR during the forecast period Based on end user, the Cell Analysis Market is segmented into hospitals & diagnostic laboratories, research institutes, pharmaceutical & biotechnology companies and CROs, cell culture collection repositories, and other end users. The pharmaceutical & biotechnology companies and CROs segment is expected to register the highest CAGR during the forecast period. These facilities use cell analysis instruments and consumables during various stages of drug discovery, drug research and development, pharmacokinetics, toxicology, and clinical studies. Growing regulatory approvals for cell culture-based vaccines, increasing pharmaceutical R&D expenditure, and commercial expansion of various pharmaceutical companies are driving the growth of this end-user segment. Get 10% Customization Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=157543946 North America was the largest regional market for cell analysis in 2018 By region, the Cell Analysis Market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest market share, followed by Europe. Factors such as the presence of a favorable business environment, growing government support through funds and grants, growing number of research activities, rising number of drug discovery initiatives by pharmaceutical & biotechnology companies in the US, and the strong presence of key players in this region are driving the growth of the Cell Analysis Market in North America. The prominent players operating in the Cell Analysis Market are Danaher Corporation (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Merck KGaA (Germany), GE Healthcare (US), Agilent Technologies, Inc. (US), Olympus Corporation (Japan), PerkinElmer, Inc. (US), Promega Corporation (US), Tecan Group (Switzerland), Miltenyi Biotec (Germany), Carl Zeiss (Germany), Bio-Rad Laboratories Inc (US), and Sysmex Corporation (Japan). Urology Devices Market worth $46.4 billion by 2026 - Exclusive Report by MarketsandMarkets™12/7/2021 According to the new market research report "Urology Devices Market by Product ((Dialysis, Endoscopes, Lasers, Lithotripsy, Robotic System), (Guidewires, Catheters, Stents)), Application(Kidney Diseases, Urological Cancer, BPH), End User(Hospital, Dialysis Center, Homecare) - Global Forecast to 2026", published by MarketsandMarkets™, the market is projected to reach USD 46.4 billion by 2026 from USD 38.0 billion in 2021, at a CAGR of 4.1%.
Browse in-depth TOC on "Urology Devices Market" 122 – Tables 36 – Figures 198 – Pages Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173062212 The rising incidence and prevalence of urological conditions drives growth in the urology devices market, growing preference for minimally invasive procedures, and the growing number of hospitals and investments in endoscopy and laparoscopy facilities are among the other factors. Emerging economies such as China and Japan are providing lucrative opportunities for the players operating in the market. The instruments segment accounted for the largest share of the urology devices market, by product segment, in 2020 Based on product, the market is segmented into instruments and consumables & accessories. The instruments segment accounted for the largest share of the market in 2020. This segment includes dialysis devices, endoscopes, laser and lithotripsy devices, robotic systems, endovision and imaging systems, insufflators, endoscopy fluid management systems, and urodynamic systems. The dialysis devices segment accounted for the largest share of the urology instruments market in 2020. The large share of this segment can be attributed to the growing patient pool of CKD due to the rising geriatric population. Urological cancer and BPH segment to register the highest growth rate during the forecast period The urology devices market is segmented into kidney diseases, urological cancer and BPH, pelvic organ prolapse, and other applications based on application. In 2020, the urological cancer and BPH segment accounted for the highest growth rate. This can be attributed to the rising incidence of urological cancers coupled with the growing number of cancer-related surgeries. The hospitals, ASCs, and clinics segment accounted for the largest share of the urology devices market, by end user segment, in 2020 Based on end users, the market is segmented into hospitals, ASCs, and clinics; dialysis centers; and home care settings. In 2020, the hospitals, ASCs, and clinics segment accounted for the largest share of the market. The improving healthcare infrastructure in developing countries such as India, the rising number of target procedures, and the rising number of surgeries are the major factors driving this segments growth. Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=173062212 North America is the largest regional market for urology devices market the market is segmented into five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the urology devices market. The large share of this region can be attributed to the increasing healthcare expenditure, highly developed healthcare systems in the US and Canada, and increasing prevalence of chronic and lifestyle conditions. The major players operating in this urology devices market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), Olympus Corporation (Japan), B. Braun Melsungen AG (Germany), Stryker Corporation (US), KARL STORZ (Germany), Cook Medical (US), Intuitive Surgical (US), Medtronic plc (Ireland), Cardinal Health (US), Teleflex Incorporated (US), Richard Wolf GmbH (Germany), CompactCath (US), Dornier MedTech (Germany), Nikkiso Co., Ltd. (Japan), Balton Sp. z o.o. (Poland), Dialife SA (Switzerland), Maxer Endoscopy GmbH (Germany), Vimex Sp. z o.o. (Poland), Amsino International, Inc. (US), ROCAMED (Monaco), Well Lead Medical Co., Ltd. (China), Medispec (US), Medical Technologies of Georgia (Georgia), EndoMed Systems GmbH (Germany), Hunter Urology (England), J and M Urinary Catheters LLC (US), and Ribbel International Limited (India). Browse Related Reports: Urinary Catheters Market by Product (Indwelling, Intermittent, External), Type (Coated, Uncoated), Application (Urinary Incontinence, Benign Prostate Hyperplasia, General Surgery), Usage (Male, Female), End Users (Hospitals) - Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/urinary-catheter-market-132934629.html According to the new market research report "Pharmaceutical Packaging Equipment Market by Product (Aseptic Packaging, Blister, Strip, Bottle, Tube, Carton, Case Packer, Wrapping Machine, Palletizing, Labeling & Serialization), Type (Tablet, Powder, Cream, Syrup, Aerosol), Region - Global Forecast to 2025", published by MarketsandMarkets™, the global Pharmaceutical Packaging Equipment Market size is projected to reach USD 10.4 billion by 2025 from USD 7.3 billion in 2020, at a CAGR of 7.4% from 2020 to 2025.
Browse in-depth TOC on "Pharmaceutical Packaging Equipment Market" 276 – Tables 48 – Figures 330 – Pages Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19845828 The growth of the global pharmaceutical packaging equipment industry is driven by the rapidly growing generic and biopharmaceutical markets, growth in OTC drug sales, rising need for flexible and integrated packaging equipment, increased offshore manufacturing in the pharmaceuticals market, and the introduction of regulatory standards on packaging and stringent norms against counterfeiting. Primary packaging equipment accounted for the largest share in the market in the forecast period. On the basis of product, the pharmaceutical packaging equipment market is segmented into primary packaging equipment, secondary packaging equipment, and labeling and serialization equipment. In 2019, the primary packaging equipment segment accounted for the largest share of the market. The main function of primary packaging is to restrict climatic, chemical, or biological hazards that cause deterioration. The rising need for the aseptic filling and sealing of drug molecules into sterile containers and the increasing demand for parenteral vials and prefillable syringes are supporting the growth of this segment. Liquid packaging equipment expected to show the highest growth in the forecast period. Based on type, the pharmaceutical packaging equipment market is segmented into liquid, solid, semi-solid, and other packaging equipment. In 2019, the liquid packaging equipment segment accounted for the largest share of the market, followed by solid and semi-solid packaging equipment segments. The largest share can be attributed to the wide range of applications of liquid pharmaceutical dosage as they can be administered via either the oral or the parenteral route. Their palatability makes them a product of choice for geriatric and pediatric patients. Get 10% Customization on this Research Report :-https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=19845828 Europe to hold the largest share in the global market during the forecast period of 2020–2025. Geographically, the pharmaceutical packaging equipment market is segmented into North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. Growth in the European market is driven majorly by the high pharmaceutical production, increasing demand for flexible packaging equipment by major pharmaceutical manufacturers, and the rising focus on product diversification by companies, driving the demand for innovative packaging equipment. Regulatory changes are also compelling pharmaceutical manufacturers to replace their older equipment with new equipment to adhere to the changing standards. The prominent players in this market are Syntegon Technology (Germany), IMA S.p.A. (Italy), Körber AG (Germany), Uhlmann Group (Germany), OPTIMA Packaging Group (Germany), Romaco Holding (Germany), Marchesini Group (Italy), ACG Worldwide (India), Coesia S.p.A. (Italy) and MULTIVAC Group (Germany). According to a new market research report " Medical Image Analysis Software Market by Type (Standalone), Images (2D, 3D, 4D), Modality (CT, MRI, PET, Ultrasound), Application (Orthopedic, Dental, Oncology, Nephrology), End User (Hospital, Diagnostic Centre, Research) - Global Forecasts to 2022", published by MarketsandMarkets™, the market is expected to reach USD 3.88 Billion by 2022 from USD 2.61 Billion in 2017, at a CAGR of 8.2% during the forecast period.
Browse in-depth TOC on " Medical Image Analysis Software Market " 303 – Tables 43 – Figures 313 – Pages Download PDF Brochure:- http://www.marketsandmarkets.com/pdfdownload.asp?id=846 The growth of the market is attributed to technological advancements in medical imaging systems & analysis software, growing public- and private-sector investments in the medical imaging market, increasing use of imaging equipment due to rising prevalence of chronic diseases, fusion of imaging technologies, and growing applications of computer-aided diagnosis. Growing need for automated image analysis tools, rising adoption of cloud-based imaging solutions, and untapped emerging markets are expected to offer significant growth opportunities for manufacturers in the coming years. Integrated software to dominate the market in 2017 Based on type, the Medical Image Analysis Software Market is segmented into integrated and standalone software. In 2017, the integrated software segment is expected to account for the largest share of the Medical Image Analysis Software Market. The compatibility of the software with the equipment is examined by the manufacturer beforehand and easy handling and fast processing are additional factors that contribute to the adoption of integrated image analysis software. However, the standalone software segment is expected to grow at the highest CAGR during the forecast period. Standalone software offers high flexibility and easy-to-use tools to inspect, evaluate, and process imaging data. These advantages are driving its growth in the market. On the basis of end user, hospitals are projected to grow at the highest CAGR By end user, the Medical Image Analysis Software Market is segmented into hospitals, diagnostic centers, and research centers. Hospitals are expected to register the highest CAGR during the forecast period. The greater use of medical imaging software in hospitals & the higher installed base of diagnostic imaging systems (as compared to diagnostic and research centers) and high patient inflow (as compared to diagnostic centers) are expected to boost the demand for medical image analysis software in this segment. North America to dominate the market followed by Europe In 2017, North America is expected to account for the largest share of the market. The high growth of the North American market is attributed to the factors such as the growing geriatric population, high incidence/prevalence of various diseases, the large number of imaging centers in this region, ongoing research, fast adoption of technologically advanced imaging systems, and increasing awareness about the benefits of early disease diagnosis. In 2017, Europe is expected to hold the second largest share of this market. Talk To Our Research Analysts: -http://www.marketsandmarkets.com/speaktoanalyst.asp?id=846 Factors such as rising incidence of chronic diseases and injuries, increasing demand for non-radiation diagnostic solutions, technological advancements and new product launches, large number of ongoing research activities, and increasing government and public-private investments are expected to fuel the market growth in this region. The Medical Image Analysis Software Market is highly competitive with the presence of several small and big players. Some of the players in the Medical Image Analysis Software Market include AGFA Healthcare (Belgium), AQUILAB (France), Carestream Health, Inc. (US), Esaote S.p.A (Italy), GE Healthcare (US), Image Analysis (UK), INFINITT Healthcare Co, Ltd. (South Korea), Merge Healthcare, Inc. (US), MIM Software Inc. (US), Mirada Medical Limited (UK), Philips Healthcare (Netherlands), ScienceSoft USA Corporation (US), Siemens Healthineers (Germany), Toshiba Medical Systems Corporation (Japan), and Xinapse Systems Ltd (UK). According to the new market research report "Hemodialysis and Peritoneal Dialysis Market by Product (Machine, Bloodline, Tube, Concentrate (Alkaline), Catheter, Dialyzer, Water Treatment, Services), Modality (Conventional, CAPD, Nocturnal), User (Hospital, Home Care, ASCs) - Global Forecasts to 2026", published by MarketsandMarkets™, the global Hemodialysis Dialysis Market is projected to reach USD 105.1 billion by 2026 from USD 76.9 billion in 2021, at a CAGR of 6.4% during the forecast period.
Browse in-depth TOC on "Hemodialysis and Peritoneal Dialysis Market" 440 – Tables 48 – Figures 338 – Pages Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1279 The increasing incidence of chronic kidney disease, the availability of advanced dialysis, machines disposables and replacement fluids, and increasing government initiatives to increase the accessibility of dialysis treatment and growing adoption home hemodialysis are expected to drive market growth in the coming years The hemodialysis and peritoneal dialysis market include major Tier I and II suppliers of HD & PD products & services are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), DaVita Inc. (US), Nipro Corporation (Japan), Cantel Medical Corporation (US), Diaverum (Germany), Medtronic plc (Ireland), Rockwell Medical, Inc. (US), Becton, Dickinson and Company (US), Dialife SA (Switzerland), and Isopure Corp. (USThese suppliers have their manufacturing facilities spread across regions such as North America and Europe. COVID-19 has impacted their businesses as well. The surge in the number of COVID cases, along with the rise in its severity rate, is likely to create a potential increase in the incidence of kidney damage. Due to the pandemic, the demand for renal replacement fluids has increased significantly worldwide. The demand for RRT among patients with COVID-19 has increased fivefold compared to the historical US populations (4.9% as of 2020 VS. 0.9% earlier) (Source: American Society of Nephrology, 2021). The gradual shift towards home hemodialysis treatment before the pandemic and the concerns over the spread of COVID-19 infection have considerably accelerated patient interest in HD treatment. This factor is likely to boost the adoption of home hemodialysis products during the epidemic. The rise in number of dialysis service provider to support the market growth during the forecast period." Significant rise in number of dialysis service provider, coupled with the growing prevalence of ESRD. Along with this growing focus of dialysis service providers towards expansion of their services offerings by launching and acquiring new dialysis centers across the globe is likely to contribute towards the growth of the segment. Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=1279 Asia Pacific likely to emerge as the fastest-growing hemodialysis and peritoneal dialysis market, globally Geographically, the emerging Asian countries, such as China, India, Japan and Singapore, are offering high-growth opportunities for market players. The Asia Pacific point of care market is projected to grow at the highest CAGR of 8.8% from 2021 to 2026. Expansion of healthcare infrastructure and increase in disposable personal income, increase patient population with acute kidney disease, diabetes, hypertension are factors likely to support the growth of hemodialysis and peritoneal dialysis market in the region. Moreover, initiative by government to increase the accessibility of the dialysis treatment in the region are likely to offer huge opportunity for the players to capture large customer base. Prominent players in this Hemodialysis Market are Baxter International Inc. (US), Fresenius Medical Care AG & Co. KGaA (Germany), NIKKISO CO., LTD. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), Toray Medical Co., Ltd. (Japan), among others Browse Related Reports: China Hemodialysis and Peritoneal Dialysis Market by Product & Services (HD, PD, Machine, Dialyzer, Concentrate, Dialysate, Catheter, Service), Modality (CAPD, APD, Nocturnal), End User (Hospital, Independent Center, Home Dialysis) - Forecast to 2024https://www.marketsandmarkets.com/Market-Reports/china-hemodialysis-peritoneal-dialysis-market-150472097.html Urology Devices Market by Product ((Dialysis, Endoscopes, Lasers, Lithotripsy, Robotic System), (Guidewires, Catheters, Stents)), Application(Kidney Diseases, Urological Cancer, BPH), End User(Hospital, Dialysis Center, Homecare) - Global Forecast to 2026https://www.marketsandmarkets.com/Market-Reports/urology-devices-market-173062212.html |
AuthorWe are providing and consulting the healthcare Industry Research Report. Archives
March 2022
Categories |